Antimicrobial Drugs
Key Focus Areas
Pharmacological properties of drugs
Mechanisms of action
Side effects
Antimicrobial Drugs
Describe properties and actions of main classes: - Anti-folates - Cell wall synthesis inhibitors - Protein synthesis inhibitors - DNA synthesis inhibitors
Inhibitors of Folate Synthesis
Examples: sulfanilamide, trimethoprim
Folate vital for DNA synthesis; bacteria synthesize it while humans do not.
Selective toxicity due to uptake differences.
Notable antibiotic: Prontosil (metabolizes to sulfanilamide).
Key Enzymes in Folate Synthesis
Dihydropteroate synthetase: Bacterial enzyme crucial for folic acid synthesis.
Dihydrofolate reductase: More sensitive in bacteria than in humans; inhibited by trimethoprim.
Cell Wall Synthesis Inhibitors
Beta-lactams: e.g. penicillins, amoxicillin - Mechanism: Inhibit transpeptidase, leading to cell lysis. - Side effects: Hypersensitivity, risk of anaphylaxis. - Resistance issues: Caused by beta-lactamase enzymes; countered with beta-lactamase inhibitors (e.g., clavulanic acid).
Glycopeptides: e.g. vancomycin - Mechanism: Binds to specific cell wall precursors, inhibits synthesis - Side effects: Autotoxicity, nephrotoxicity.
Protein Synthesis Inhibitors
Ribosomal Differences: Bacterial (30s, 50s) vs Mammalian (40s, 60s) allow selective toxicity.
Classes of inhibitors: - Tetracyclines (e.g. doxycycline): reversible binding to the 30s subunit. Side effects include discoloration of teeth. - Aminoglycosides (e.g. streptomycin): bind irreversibly to the 30s subunit. - Macrolides (e.g. erythromycin): bind to 50s subunit. - Chloramphenicol: severe side effects; inhibits mitochondrial protein synthesis. - Lincosamides (e.g. clindamycin): effect varies with dose. - Oxazolidinones (e.g. linezolid): interferes with ribosomal assembly.
Inhibitors of DNA Synthesis
Fluoroquinolones (e.g. ciprofloxacin): inhibit DNA gyrase, have bactericidal activity.
Nitroimidazoles (e.g. metronidazole): binds and inhibits DNA synthesis in anaerobic bacteria.
Antibiotic Resistance Mechanisms
Enzymatic inactivation (e.g. beta-lactamases)
Altered pathways and binding sites
Decreased drug uptake
Summary of Key Antibiotics
Linezolid, ciprofloxacin, co-trimoxazole, amoxicillin, penicillin, cefotaxime, clavulanic acid, vancomycin, tetracycline, streptomycin, chloramphenicol, erythromycin, sulfanilamide, metronidazole